Schizophrenia

Schizophrenia is a chronic debilitating disorder which affects more than two million Americans, and millions more worldwide. While significant progress has been made in understanding the disease and developing treatments, there remains a significant unmet medical need. More than 50% of patients switch their medication in a given year due to either poor response or the experience of adverse events.

Schizophrenia

Schizophrenia is a chronic mental health disorder that causes people to think, feel and perceive the world differently to the general population. It is characterized by episodes of psychosis, usually with hallucinations or delusions.

Schizophrenia Diagnosis

Schizophrenia Causes

Schizophrenia Signs and Symptoms

Schizophrenia Neural Processes

Schizophrenia Mechanisms

Schizophrenia Screening, Prevention and Management

Schizophrenia Medication

Schizophrenia Interventions

Schizophrenia Prognosis

Latest Schizophrenia News and Research

Scientists identify molecular mechanism behind weight gain in patients taking antipsychotics

Scientists with UT Southwestern's Peter O'Donnell Jr. Brain Institute have identified the molecular mechanism that can cause weight gain for those using a common antipsychotic medication.

12 May 2021

Covid-19 patients show reduced gray matter volume in the brain

Covid-19 patients who receive oxygen therapy or experience fever show reduced gray matter volume in the frontal-temporal network of the brain, according to a new study led by researchers at Georgia State University and the Georgia Institute of Technology.

12 May 2021

Cerebral organoids provide new insight into role of key enzyme in natural brain development

Like many around the world, the lab of Professor Mriganka Sur in The Picower Institute for Learning and Memory at MIT has embraced the young technology of cerebral organoids, or "minibrains," for studying human brain development in health and disease.

11 May 2021

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19

Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19.

5 May 2021

Brain thinning in youth associated with psychosis

Subtle differences in the shape of the brain that are present in adolescence are associated with the development of psychosis, according to an international team led by neuroscientists at the University of Pittsburgh School of Medicine and Maastricht University in the Netherlands.

5 May 2021

Partners to people with schizophrenia, bipolar disorder also meet diagnostic criteria for mental disorder

Almost half of the parents who have children together with a parent with schizophrenia or bipolar disorder, are themselves burdened by psychological issues. This can affect family life and the children. This is shown in the research result from the major Danish psychiatry project iPSYCH.

4 May 2021

Scientists investigate the role played by genes and environment in multiple substance use

Many drug addicts take not only one substance but rather several. Scientists at the Max Planck Institute of Experimental Medicine in Göttingen have investigated the role that genes and the environment play in the development of such multiple substance consumption or polytoxicomania.

3 May 2021

Mental health services wane as insurers appear to skirt parity rules during pandemic

Therapists and other behavioral health care providers cut hours, reduced staffs and turned away patients during the pandemic as more Americans experienced depression symptoms and drug overdoses, according to a new report from the Government Accountability Office.

30 Apr 2021

BrainMap analysis strongly affirms 'network degeneration hypothesis' theory

The brain possesses a complex architecture of functional networks as its information-processing machinery. Is the brain's network architecture itself a target of disease? If so, which networks are associated with which diseases? What can this tell us about the underlying causes of brain disorders?

29 Apr 2021

New imaging technique captures movies of receptors on the surface of living cells

A new imaging technique developed by scientists at Columbia University Vagelos College of Physicians and Surgeons and St. Jude Children's Research Hospital captures movies of receptors on the surface of living cells in unprecedented detail and could pave the way to a trove of new drugs.

23 Apr 2021

Blood-brain barrier and its effect on the immune system play a role in schizophrenia

Like a stern bodyguard for the central nervous sytem, the blood-brain barrier keeps out anything that could lead to disease and dangerous inflammation--at least when all is functioning normally.

21 Apr 2021

Simple dietary supplement ameliorates schizophrenic traits in mice

A simple dietary supplement reduces behavioral symptoms in mice with a genetic mutation that causes schizophrenia.

19 Apr 2021

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19

Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19.

16 Apr 2021

Airports step up mental health assistance as passenger anxiety soars

Robin Hancock gently worked her steel tongue drum with a pair of mallets, producing a set of soothing, mystical tones. They blended with the soft sound of chirping birds and bubbling creeks pouring from a Bluetooth speaker. Her warm voice invited the two visitors in the dimly lit room to slip into a nature setting of their choosing.

15 Apr 2021

Linkam FDCS196 stage used in research to develop a novel transdermal delivery system for risperidone

The first study of its kind reports on the enhancement of skin permeability of risperidone (RIS) using eutectic systems.

From Linkam Scientific Instruments 14 Apr 2021

Cannabis users genetically predisposed to schizophrenia may have higher risk for psychosis

It has been long been known that cannabis users develop psychosis more often than non-users, but what is still not fully clear is whether cannabis actually causes psychosis and, if so, who is most at risk.

13 Apr 2021

Inhibition of nsp14 methyltransferase as a potential antiviral target for SARS-CoV-2

Beyond vaccination, the broad-spectrum antiviral medication remdesivir has robust clinical evidence and is known as the best antiviral treatment to reduce severe COVID-19 infection in hospitalized patients. Research led by John F.X. Diffley of the Chromosome Replication Laboratory suggests a potential therapeutic target for treatment development is the viral RNA cap methyltransferases, essential for viral protein translation and immune evasion.

13 Apr 2021

Marshall University researcher awarded $399,600 NIH grant to study sex differences in brain development

W. Christopher Risher, Ph.D., an assistant professor of biomedical sciences at the Marshall University Joan C. Edwards School of Medicine, has been awarded a $399,600 grant from the National Institutes of Health for his research on the differences in brain development between males and females.

12 Apr 2021

Study explains future ethical implications of brain organoid research

Stem cell research has allowed medicine to go places that were once science fiction. Using stem cells, scientists have manufactured heart cells, brain cells and other cell types that they are now transplanting into patients as a form of cell therapy.

9 Apr 2021

Researchers identify nonelectrical cells that transition the brain from plasticity to stability

Researchers exploring the developing central nervous system of fruit flies have identified nonelectrical cells that transition the brain from highly plastic into a less moldable, mature state.

8 Apr 2021

Schizophrenia

Overview

Schizophrenia Diagnosis

Schizophrenia Causes

Schizophrenia Signs and Symptoms

Feature Articles

Schizophrenia Neural Processes

Schizophrenia Mechanisms

Schizophrenia Screening, Prevention and Management

Schizophrenia Medication

Schizophrenia Interventions

Schizophrenia Prognosis

Latest Schizophrenia News and Research

Scientists identify molecular mechanism behind weight gain in patients taking antipsychotics

Covid-19 patients show reduced gray matter volume in the brain

Cerebral organoids provide new insight into role of key enzyme in natural brain development

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19

Brain thinning in youth associated with psychosis

Partners to people with schizophrenia, bipolar disorder also meet diagnostic criteria for mental disorder

Scientists investigate the role played by genes and environment in multiple substance use

Mental health services wane as insurers appear to skirt parity rules during pandemic

BrainMap analysis strongly affirms 'network degeneration hypothesis' theory

New imaging technique captures movies of receptors on the surface of living cells

Blood-brain barrier and its effect on the immune system play a role in schizophrenia

Simple dietary supplement ameliorates schizophrenic traits in mice

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19

Airports step up mental health assistance as passenger anxiety soars

Linkam FDCS196 stage used in research to develop a novel transdermal delivery system for risperidone

Cannabis users genetically predisposed to schizophrenia may have higher risk for psychosis

Inhibition of nsp14 methyltransferase as a potential antiviral target for SARS-CoV-2

Marshall University researcher awarded $399,600 NIH grant to study sex differences in brain development

Study explains future ethical implications of brain organoid research

Researchers identify nonelectrical cells that transition the brain from plasticity to stability

Asthma Awareness: Fighting Asthma in 2021

World Asthma Day 2021: How could smart inhalers improve asthma care?

Fighting malaria in 2021: Where are we now and where are we going?

Schizophrenia

Overview

Feature Articles

Schizophrenia Neural Processes

Schizophrenia Mechanisms

Schizophrenia Screening, Prevention and Management

Schizophrenia Medication

Schizophrenia Interventions

Schizophrenia Prognosis

Latest Schizophrenia News and Research

Newsletters you may be interested in